1. Home
  2. XXII vs NAOV Comparison

XXII vs NAOV Comparison

Compare XXII & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XXII
  • NAOV
  • Stock Information
  • Founded
  • XXII 1998
  • NAOV 2003
  • Country
  • XXII United States
  • NAOV United States
  • Employees
  • XXII N/A
  • NAOV N/A
  • Industry
  • XXII Medicinal Chemicals and Botanical Products
  • NAOV Industrial Specialties
  • Sector
  • XXII Health Care
  • NAOV Health Care
  • Exchange
  • XXII Nasdaq
  • NAOV Nasdaq
  • Market Cap
  • XXII 2.1M
  • NAOV 2.4M
  • IPO Year
  • XXII N/A
  • NAOV N/A
  • Fundamental
  • Price
  • XXII $1.08
  • NAOV $1.23
  • Analyst Decision
  • XXII
  • NAOV
  • Analyst Count
  • XXII 0
  • NAOV 0
  • Target Price
  • XXII N/A
  • NAOV N/A
  • AVG Volume (30 Days)
  • XXII 603.9K
  • NAOV 1.6M
  • Earning Date
  • XXII 05-13-2025
  • NAOV 05-27-2025
  • Dividend Yield
  • XXII N/A
  • NAOV N/A
  • EPS Growth
  • XXII N/A
  • NAOV N/A
  • EPS
  • XXII N/A
  • NAOV N/A
  • Revenue
  • XXII $23,869,000.00
  • NAOV $2,558,000.00
  • Revenue This Year
  • XXII $19.23
  • NAOV N/A
  • Revenue Next Year
  • XXII $81.05
  • NAOV N/A
  • P/E Ratio
  • XXII N/A
  • NAOV N/A
  • Revenue Growth
  • XXII N/A
  • NAOV 12.05
  • 52 Week Low
  • XXII $0.70
  • NAOV $1.92
  • 52 Week High
  • XXII $226.80
  • NAOV $16.25
  • Technical
  • Relative Strength Index (RSI)
  • XXII 47.15
  • NAOV 26.85
  • Support Level
  • XXII $1.06
  • NAOV $3.86
  • Resistance Level
  • XXII $1.26
  • NAOV $4.45
  • Average True Range (ATR)
  • XXII 0.17
  • NAOV 0.54
  • MACD
  • XXII 0.04
  • NAOV -0.35
  • Stochastic Oscillator
  • XXII 49.25
  • NAOV 2.26

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Share on Social Networks: